91吃瓜

Autophagy is a vital cellular process that involves the degradation and recycling of damaged or unnecessary cellular components through lysosomal pathways. It plays an essential role in maintaining cellular homeostasis, regulating energy balance, and protecting cells from stress-induced damage. While autophagy is typically considered a protective mechanism, its role in cancer and inflammation is more complex, as it can function in both tumor-suppressive and tumor-promoting capacities depending on the cellular context. In the tumor microenvironment, autophagy can influence both the development of cancer and the immune response. This dual role of autophagy in cancer progression and immune regulation underscores its importance in shaping tumorigenesis and the inflammatory response. Understanding how autophagy modulates these processes is critical for developing novel therapeutic strategies that either promote or inhibit autophagic pathways in cancer treatment [1].

Description

Autophagy and tumorigenesis

Autophagy plays a critical role in cancer by regulating various cellular processes that can influence tumor initiation, progression, and metastasis. The effect of autophagy on tumorigenesis is context-dependent, meaning that it can either inhibit or promote cancer depending on the stage of cancer development and the tumor’s microenvironment.

Tumor suppression: In the early stages of cancer, autophagy acts as a tumor-suppressive mechanism by preventing the accumulation of damaged proteins and organelles, which could otherwise lead to genomic instability and mutations [2]. Autophagy also helps eliminate potentially oncogenic proteins and damaged mitochondria, thus reducing the risk of tumor initiation. Furthermore, autophagy is crucial in maintaining the homeostasis of the tumor suppressor protein p53, which plays a central role in preventing tumorigenesis.

Tumor promotion: In established tumors, autophagy can be hijacked to promote cancer cell survival under stressful conditions such as nutrient deprivation, hypoxia, or chemotherapy. Cancer cells often experience increased metabolic stress, and autophagy enables these cells to adapt to hostile microenvironments by providing essential nutrients and energy. Autophagy also supports the survival of cancer stem cells, which are responsible for tumor recurrence and metastasis. In some cancer types, the upregulation of autophagy pathways has been linked to resistance to chemotherapy and radiation, as these treatments can induce cell death that is counteracted by autophagic processes [3].

Autophagy and the tumor microenvironment: The tumor microenvironment (TME) is highly dynamic and comprises cancer cells, stromal cells, immune cells, and extracellular matrix components. Autophagy influences the TME in multiple ways, including the modulation of immune responses. Autophagic activity within tumor-associated macrophages (TAMs), for example, can affect the inflammatory milieu of the TME, influencing tumor growth and metastasis [4]. Tumors that enhance autophagy in their stroma or immune cells may promote an immune-suppressive environment, which allows them to evade immune surveillance and thrive.

Autophagy and inflammation

Inflammation is a key driver of cancer progression, and autophagy plays a crucial role in regulating both the onset and resolution of inflammation. The inflammatory response is essential for immune defense, but chronic or uncontrolled inflammation can lead to tissue damage, promoting cancer development. Autophagy can have a significant impact on the inflammatory process, both in the context of tumor-associated inflammation and in systemic inflammatory diseases [5].

Inflammatory cytokine regulation: Autophagy can regulate the production of inflammatory cytokines by controlling the degradation of signaling molecules involved in the inflammatory cascade. For example, autophagy has been shown to limit the activation of pro-inflammatory pathways, such as the NF-κB pathway, by degrading certain signaling proteins that promote inflammation. In this way, autophagy helps modulate the intensity and duration of the inflammatory response [6]. However, in some contexts, autophagy can exacerbate inflammation by facilitating the release of damage-associated molecular patterns (DAMPs) or activating inflammasomes, protein complexes that play a role in the inflammatory response.

Immune cell function: Autophagy plays a key role in the regulation of immune cell function, particularly in dendritic cells, macrophages, and T cells, which are essential for the immune response to tumors and infections. Autophagy in these cells can influence the activation of antigen presentation, phagocytosis, and cytokine secretion, all of which are critical for the immune system’s ability to detect and eliminate cancer cells. In macrophages, autophagy is involved in the polarization of these cells into pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes, which can either promote or suppress tumor progression.

Chronic inflammation and cancer: Chronic inflammation is a hallmark of many cancers, and autophagy is often involved in sustaining this inflammatory state [7]. Inflammatory cells in the tumor microenvironment, such as macrophages and neutrophils, can undergo autophagy to promote the release of cytokines and chemokines that foster a pro-tumorigenic inflammatory environment. Autophagic processes in the TME can enhance angiogenesis, support tumor cell survival, and contribute to immune evasion, further exacerbating the inflammatory cycle and driving cancer progression.

Autophagy in immune evasion: Tumor cells can exploit autophagy to evade immune detection. Autophagy-induced cell death, also known as type II programmed cell death, may prevent the release of antigens necessary for immune activation. Furthermore, autophagic activity in tumor-associated immune cells can modulate the immune response to reduce the activity of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, which are essential for targeting and destroying cancer cells. By manipulating autophagy in immune cells, tumors can create a more favorable environment for their survival and growth [8].

Dual roles of autophagy in cancer and inflammation

The dual roles of autophagy in cancer and inflammation complicate its therapeutic targeting. While autophagy can suppress tumor initiation by maintaining cellular homeostasis and preventing inflammation, it can also support tumor growth and metastasis by promoting cancer cell survival and immune evasion. The role of autophagy in inflammation further complicates matters, as it can either reduce chronic inflammation and prevent tumor progression or exacerbate inflammation and fuel cancer development [9].

For example, in the early stages of cancer, autophagy may be beneficial by reducing genomic instability and modulating the immune system in favor of tumor suppression. In contrast, in later stages or during therapy, autophagy may contribute to therapy resistance by promoting the survival of tumor cells or immune cells that facilitate tumor progression. The ability of autophagy to regulate both immune responses and inflammation adds another layer of complexity, as manipulating autophagic pathways may affect immune cell function and cytokine production [10].

Conclusion

Autophagy plays a multifaceted role in cancer and inflammation, with both tumor-suppressive and tumor-promoting effects depending on the context. On one hand, autophagy helps maintain cellular homeostasis and prevents tumor initiation by controlling inflammation and promoting the degradation of damaged cellular components. On the other hand, once a tumor is established, autophagy can promote cancer cell survival under stress conditions, support tumor metastasis, and help tumors evade immune surveillance.The dual nature of autophagy in cancer progression and immune regulation presents both challenges and opportunities for therapeutic intervention. Targeting autophagic pathways requires a nuanced approach that takes into account the specific stage of cancer development, the tumor microenvironment, and the immune landscape. Developing therapies that modulate autophagy could hold promise for improving cancer treatment outcomes, either by promoting autophagic pathways in early cancer stages or inhibiting them in advanced or therapy-resistant tumors. Further research into the molecular mechanisms underlying autophagy’s dual roles in cancer and inflammation will be essential for the development of more effective and personalized cancer therapies.

Acknowledgement

None

Conflict of Interest

None

1. Rao V, Agarwal S (2000) . J Am Coll Nutrit 19: 563-569.

, ,

2. Li F, Awale S, Tezuka Y, Esumi H, Kadota S (2010) . J Nat Prod 73: 623-627.

, ,

3. Sawicka D, Car H, Borawska M, Nikli艅ski J (2012) . Folia Histochem Cytobiol 50: 25-37.

, ,

4. Yin T, Shi P, Gou S, Shen Q, Wang C (2014) . Plos One 9: e114581.

,

5. Li Y, Wicha M, Schwartz S, Sun D (2011. J Nutr Biochem 22: 799-806.

, ,

6. Suzuki R, Kang Y, Li X, Roife D, Zhang R, et al. (2014) . Anticancer Res 34: 4685-4692.

,

7. Ma J, Cheng L, Liu H, Sarkar F, Xia J, et al. (2013) . Current Drug Targets 14: 1150-1156.

, ,

8. El-Rayes B, Ali S, Ali I, Philip P, Abbruzzese J et al. (2006) . Cancer Res 66: 10553-10559.

, ,

9. Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, et al. (2005. Cancer Res 5: 9064-9072.

, ,

10. Han L, Zhang HW, Zhou WP, Chen GM, Guo KJ (2012) . Chin Med 125: 2032-2040.

, , Crossref